We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+2.25%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$203M
AUM Growth
+$6.95M
Cap. Flow
+$3.45M
Cap. Flow %
1.7%
Top 10 Hldgs %
24.55%
Holding
99
New
4
Increased
34
Reduced
35
Closed
2

Top Buys

Rank Stock Value
1
GIS icon
General Mills
GIS
+$2.77M
2
IBB icon
iShares Biotechnology ETF
IBB
+$356K
3
CL icon
Colgate-Palmolive
CL
+$345K
4
CVS icon
CVS Health
CVS
+$285K
5
GE icon
GE Aerospace
GE
+$272K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$618K
2
MA icon
Mastercard
MA
+$472K
3
BBH icon
VanEck Biotech ETF
BBH
+$315K
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$228K
5
CLX icon
Clorox
CLX
+$212K

Sector Composition

Rank Sector Weight
1 Technology 14.43%
2 Industrials 13.17%
3 Healthcare 12.14%
4 Financials 10.95%
5 Consumer Staples 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.99T
$6.98M 3.44%
70,799
-960
-1% -$93K
CSCO icon
2
Cisco
CSCO
$436B
$5.5M 2.71%
127,759
-1,715
-1% -$74.9K
INTC icon
3
Intel
INTC
$488B
$5.36M 2.64%
107,899
-1,170
-1% -$62.1K
MA icon
4
Mastercard
MA
$484B
$5.17M 2.54%
26,292
-2,510
-9% -$472K
AAPL icon
5
Apple
AAPL
$4.8T
$4.99M 2.45%
107,760
+40
+0% +$1.81K
IJR icon
6
iShares Core S&P Small-Cap ETF
IJR
$109B
$4.79M 2.36%
57,464
+619
+1% +$50.4K
IVV icon
7
iShares Core S&P 500 ETF
IVV
$879B
$4.37M 2.15%
16,007
-129
-0.8% -$35.1K
ABBV icon
8
AbbVie
ABBV
$448B
$4.29M 2.11%
46,319
-245
-0.5% -$23.9K
ACN icon
9
Accenture
ACN
$88.6B
$4.27M 2.1%
26,116
-185
-0.7% -$28.8K
MMM icon
10
3M
MMM
$83B
$4.17M 2.05%
25,343
+861
+4% +$147K
XOM icon
11
ExxonMobil
XOM
$615B
$4.15M 2.04%
50,196
-2,410
-5% -$192K
WMT icon
12
Walmart Inc
WMT
$893B
$4.03M 1.98%
141,108
-885
-0.6% -$25.2K
IEMG icon
13
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$3.97M 1.95%
75,610
+216
+0.3% +$12.1K
LH icon
14
Labcorp
LH
$23.1B
$3.91M 1.92%
25,330
-756
-3% -$114K
PEP icon
15
PepsiCo
PEP
$185B
$3.89M 1.92%
35,768
+1,515
+4% +$156K
COP icon
16
ConocoPhillips
COP
$141B
$3.83M 1.89%
55,086
-1,500
-3% -$99.9K
MCD icon
17
McDonald's
MCD
$190B
$3.77M 1.86%
24,092
-570
-2% -$92.4K
XYL icon
18
Xylem
XYL
$28.7B
$3.77M 1.86%
55,992
+180
+0.3% +$13.1K
IWM icon
19
iShares Russell 2000 ETF
IWM
$81.2B
$3.74M 1.84%
22,864
-790
-3% -$126K
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.06T
$3.74M 1.84%
20,048
-45
-0.2% -$8.77K
FAST icon
21
Fastenal
FAST
$51.4B
$3.64M 1.79%
302,712
+4,040
+1% +$52.3K
KO icon
22
Coca-Cola
KO
$353B
$3.6M 1.77%
82,204
+1,070
+1% +$46.2K
CHRW icon
23
C.H. Robinson
CHRW
$24.3B
$3.54M 1.74%
42,306
-370
-0.9% -$33K
ABT icon
24
Abbott
ABT
$177B
$3.53M 1.74%
57,952
-1,140
-2% -$69.1K
MDT icon
25
Medtronic
MDT
$107B
$3.52M 1.73%
41,066
+1,040
+3% +$86.9K
1
2 3 4

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
RAG
RIA Advisory Group Des Moines, Iowa $421M AUM 30.78% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
AFA
AllGen Financial Advisors Orlando, Florida $421M AUM 14.16% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return

Boston Research & Management's Q2 2018 Portfolio in Review

As of Q2 2018, Boston Research & Management held 99 positions worth $203M, up 3.5% from $196M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Boston Research & Management's Q2 2018 filing shows 4 new, 34 increased, 35 reduced and 2 closed positions. Its largest new stake was General Mills: 63,350 shares worth $2.8M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $618K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Research & Management's largest Q2 2018 buy was General Mills: 63,350 shares worth $2.8M.
  • Boston Research & Management added most to iShares Biotechnology ETF in Q2 2018, an estimated $356K increase.
  • Boston Research & Management's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $618K.
  • Boston Research & Management fully exited iShares MSCI EAFE ETF in Q2 2018, selling an estimated $228K.
  • Boston Research & Management's ten largest holdings make up 25% of its $203M portfolio in Q2 2018.
  • Boston Research & Management opened 4 new positions and closed 2 in Q2 2018.
  • Boston Research & Management's portfolio value rose 3.5% quarter-over-quarter to $203M.

Based on Boston Research & Management's 13F filing for Q2 2018, filed 30 Jul 2018.